FDA Clearance Tracker · P070001-S025
prodisc C SK and prodisc C Vivo
Last checked: Nov 20, 2026Latest source record: Oct 10, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Oct 10, 2025
Approved
Time to decision
744 days
Received Sep 27, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P070001-S025
- Device name
- prodisc C SK and prodisc C Vivo
- Applicant
- Centinel Spine, LLC
- Applicant location
- West Chester, PA
- Received
- Sep 27, 2023
- Decided
- Oct 10, 2025
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P070001
Device type
- Device type
- Prosthesis, intervertebral disc (MJO)
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
The prodisc® C SK and prodisc® C Vivo are both indicated for use in skeletally mature patients for reconstruction of the disc from C3-C7 following discectomy at one or two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to abnormality localized to the level of the disc space and at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. The prodisc® C SK and prodisc® C Vivo are implanted using an anterior approach. Patients should have failed at least 6 weeks of conservative treatment or demonstrated progressive signs or symptoms despite non-operative treatment prior to implantation of the prodisc® C SK and prodisc® C Vivo.
Source documents
Other decisions for Centinel Spine, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263159 · Decided Oct 7, 2026 · 28 days after receipt
Device type: Manual Instruments Designed For Use With Total Disc Replacement Devices (QLQ) · Orthopedic Surgery
- prodisc® L Instruments510(k)
K250554 · Decided Apr 25, 2025 · 59 days after receipt
Device type: Manual Instruments Designed For Use With Total Disc Replacement Devices (QLQ) · Orthopedic Surgery
- prodisc® L Instruments510(k)
K242869 · Decided Dec 17, 2024 · 88 days after receipt
Device type: Manual Instruments Designed For Use With Total Disc Replacement Devices (QLQ) · Orthopedic Surgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.